Press Releases September 25, 2026 06:00 AM

Kyivstar Capital Markets Day 2026

Kyivstar announces Capital Markets Day at Nasdaq to showcase strategic priorities and outlook in 2026

By Ajmal Hussain
Share
Twitter Reddit Facebook LinkedIn
KYIV

Kyivstar Group Ltd., the leading Ukrainian digital operator and first Ukrainian company listed on Nasdaq, will hold its Capital Markets Day on November 17, 2026, at Nasdaq MarketSite in New York. The event will include presentations on company strategy, performance, and future outlook, and will be accessible in person or via webcast.

Kyivstar Capital Markets Day 2026
KYIV
Summarize with
ChatGPT Perplexity Claude Grok Gemini

Key Points

  • Kyivstar is hosting a Capital Markets Day at Nasdaq to present strategic priorities and business performance.
  • The event will take place in-person in New York and virtually via webcast on November 17, 2026.
  • Kyivstar is Ukraine's leading digital operator, offering mobile, fixed-line, digital services, and enterprise solutions including Big Data, cloud, and cybersecurity.
  • The company is the first Ukrainian firm listed on a U.S. stock exchange (Nasdaq: KYIV, KYIVW).

KYIV, Ukraine and DUBAI, United Arab Emirates and NEW YORK, Sept. 25, 2026 (GLOBE NEWSWIRE) -- Kyivstar Group Ltd. (Nasdaq: KYIV; KYIVW) (“Kyivstar” or “the Group”), Ukraine’s leading digital operator and the first Ukrainian company to trade on Nasdaq, today announces registration details for its Capital Markets Day on Tuesday, November 17, 2026, at the Nasdaq MarketSite in New York City.

The event will begin promptly at 9:00 ET and feature presentations by Kyivstar’s senior management on the Group’s strategic priorities, business performance, and outlook. Participants are invited to attend in person or join virtually via webcast.

In-person attendance

Nasdaq MarketSite
151 West 43rd Street, 10th Floor, Times Square, New York, NY 10036
Tuesday, November 17, 2026, 9:00 ET.

Attendees should arrive by 8:30 ET to allow time for registration and security checks.

In-person attendance at the Capital Markets Day is subject to prior registration and confirmation. Investors and analysts wishing to attend in person may email to [email protected]. Participants are encouraged to register at their earliest convenience and no later than Friday, November 6, 2026. Confirmed attendees will be required to present a valid photo ID upon arrival.

Registration details will be shared with Nasdaq for access coordination. Registered attendees will receive a separate Nasdaq access link approximately 24 hours before the event with instructions for ID registration, verification, and building entry. Attendees must complete these steps in advance and bring valid government-issued photo ID for entry.

Virtual participation

Virtual participants are required to register for the event via the webcast link provided: https://brrmedia.news/Kyivstar_CMD_2026

A webcast replay and related presentation materials will be available on Kyivstar’s investor relations website after the event.

About Kyivstar Group Ltd.
Kyivstar Group Ltd. (“Kyivstar”) is a Nasdaq-listed holding company that operates JSC Kyivstar, Ukraine’s leading digital operator and the first Ukrainian company to list on a U.S. stock exchange. Kyivstar's companies provide a broad range of connectivity and digital services, including mobile and fixed-line voice and data, ride-hailing, e-health, digital TV, and enterprise solutions such as Big Data, cloud, and cybersecurity.

For more information, please visit https://investors.kyivstar.ua.

Nasdaq tickers: KYIV; KYIVW

Contact information:
Kyivstar Group Ltd
Investor Relations
[email protected]


Risks

  • Geopolitical and economic instability in Ukraine could impact Kyivstar's operations and financial performance.
  • Market uncertainties related to the digital and telecom sectors in Eastern Europe may affect growth outlook.
  • Potential regulatory challenges in both Ukrainian and U.S. markets could pose compliance risks.

More from Press Releases

Edible Garden Wins Third New Walmart Fresh Herb Distribution Center Award, Accelerating Expansion Across the Eastern Midwest Sep 25, 2026 Ocugen Receives Provisional Approval and Priority Designation Under the Longevity and Regenerative Therapies Act in The Bahamas to Provide OCU400 to Patients for Treatment of Retinitis Pigmentosa Sep 25, 2026 C4 Therapeutics Presents New Biomarker Data from the Cemsidomide Phase 1 Trial with Dexamethasone and Phase 1b Trial with Elranatamab (ELREXFIO®) in Relapsed/Refractory Multiple Myeloma at the 23rd International Myeloma Society (IMS) Annual Meeting Sep 25, 2026 FactSet Appoints Marcel Prins to Board of Directors Sep 25, 2026 Fate Therapeutics Announces Receipt of California Institute for Regenerative Medicine (CIRM) CLIN2 Grant to Advance RECLAIM-LN Sep 25, 2026